Skip to main content
. Author manuscript; available in PMC: 2016 Jan 14.
Published in final edited form as: Nucl Med Biol. 2011 Sep 29;39(2):215–226. doi: 10.1016/j.nucmedbio.2011.07.007

Table 2.

SUVmax in organs and tumors 60–70 min after administration of PET radioligands in mice harboring subcutaneous and organ metastatic pheochromocytomas

[18F]-DA
 [18F]-DOPA
SUVmax
(mean±S.E.M.)		 TLR TBR SUVmax
(mean±S.E.M.)		 TLR TBR
Kidney 2.41±0.45 – – 1.73±0.34 – –
Muscle 0.31±0.02 – – 0.29±0.02 – –
Liver 0.88±0.11 – – 1.33±0.14 – –
Liver <3 mm 1.61±0.17 1.83 5.19 3.01±0.27 2.26 10.38
Liver >3 mm 2.49±0.08 2.83 8.03 3.61±0.19 2.71 12.45
Adrenal
 >3 mm		 2.18±0.39 2.47 7.03 6.61±0.64 2.83 22.79
Ovary
 >3 mm		 1.99±0.27 2.26 6.41 2.59±0.32 2.83 8.93
s.c. <5 mm 0.31±0.02 0.22 1.72 2.88±0.88 2.24 7.2
s.c. >5 mm 0.35±0.12 0.27 1.94 2.00±0.06 1.56 5.0

A muscle uptake was taken as a background.